taxus ii与taxus iv研究ppt课件.pptVIP

* * * * * * 1,326 patients with single de novo lesions Lesions 10-28 mm in length, 2.5-3.75 mm in diameter; Double blind, randomized trial Bare Stent n= 652 Endpoints (2 year follow-up): TAXUS II – MACE (97% two-year clinical follow-up) – Late loss (40% two-year angiographic follow-up) TAXUS IV – MACE – angiographic results not presented TAXUS II and IV: two-year follow-up Paclitaxel-eluting stent Slow-release formulation n=662 536 patients with single de novo lesions Lesions 12 mm in length, 3.0-3.5 mm in diameter; Double blind, randomized trial Paclitaxel-eluting stent Slow-re